Immunotherapy for Pediatric Leukemia Patients

Immunotherapy for Pediatric Leukemia Patients is organized by University of Florida (UF) College of Medicine.

Release Date: May 1, 2020
Expiration Date: April 30, 2022

Accreditation:
The University of Florida College of Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives:
As a result of participation in this activity, participants should be able to:
• Learn the story behind the current outstanding cure rates for acute lymphoblastic leukemia.
• Understand the reasons why 10% of patients still relapse.
• Appreciate the awesome power of immunotherapy in relapsed patients with ALL.
• Learn of the current trials using immunotherapy to improve cure rates in newly diagnosed patients.